Your browser doesn't support javascript.
loading
Outcomes associated with apixaban vs warfarin in patients with renal dysfunction.
Hanni, Claudia; Petrovitch, Elizabeth; Ali, Mona; Gibson, Whitney; Giuliano, Christopher; Holzhausen, Jenna; Makowski, Charles; Pallisco, Amy; Patel, Nisha; Sutter, Denise; To, Long; Yost, Raymond.
Afiliação
  • Hanni C; Pharmacy Department, Beaumont Health, Royal Oak, MI.
  • Petrovitch E; Pharmacy Department, Detroit Medical Center, Detroit, MI.
  • Ali M; Pharmacy Department, Beaumont Health, Royal Oak, MI.
  • Gibson W; Pharmacy Department, Baycare Health Systems, St. Petersburg, FL.
  • Giuliano C; Wayne State University Eugene Applebaum College of Pharmacy, Detroit, MI.
  • Holzhausen J; Pharmacy Department, Ascension St. John Hospital, Detroit, MI; and.
  • Makowski C; Pharmacy Department, Beaumont Health, Royal Oak, MI.
  • Pallisco A; Pharmacy Department, Henry Ford Hospital, Detroit, MI.
  • Patel N; Pharmacy Department, Detroit Medical Center, Detroit, MI.
  • Sutter D; Pharmacy Department, Henry Ford Hospital, Detroit, MI.
  • To L; Pharmacy Department, Detroit Medical Center, Detroit, MI.
  • Yost R; Pharmacy Department, Henry Ford Hospital, Detroit, MI.
Blood Adv ; 4(11): 2366-2371, 2020 06 09.
Article em En | MEDLINE | ID: mdl-32463871
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Varfarina / Nefropatias / Anticoagulantes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Pirazóis / Piridonas / Varfarina / Nefropatias / Anticoagulantes Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans Idioma: En Ano de publicação: 2020 Tipo de documento: Article